Search results
Telix Pharmaceuticals Ltd. (Uplisting) (TLX) Announces June 14th IPO
ETF DAILY NEWS· 5 days agoTelix Pharmaceuticals Ltd. (Uplisting) (TLX) is planning to raise $202 million in an IPO on Friday,...
How an Indian government policy backfired: The unintended consequences of price regulation of...
Medical Xpress· 6 days agoIn countries without universal health insurance or developed health care systems, governments try to...
Mass. biotech job postings drop 33% last year, report shows - Boston Business Journal
The Business Journals· 2 hours agoMassachusetts’ life sciences job growth in 2023 slowed, but didn’t completely stall, as the industry...
Best Penny Stocks Under $1 To Buy Now
GoBankingRates via AOL· 5 days agoHere are the best penny stocks under $1 to invest in. Learn about factors to consider to decide which stocks under $1 are the best investments for you.
Shares in Wegovy-maker Novo Nordisk climb, touching record high levels By Investing.com
Investing.com· 5 days agoThe Danish pharmaceutical giant has seen its share price surge by more than 38% so far this year...
AstraZeneca's (AZN) Tagrisso sNDA Gets FDA's Priority Tag
Zacks via Yahoo Finance· 11 hours agoThe FDA grants priority review to AstraZeneca's (AZN) Tagrisso for treating patients with...
'If They Can Control the Flow of Information, They Can Control You': BASEDPolitics Sues To Stop...
Reason.com via Yahoo News· 9 hours agoMore Sex & Tech News • Supreme Court decisions are coming soon—possibly this week—in two major cases...
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Zacks via Yahoo Finance· 3 days agoYou can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Want the latest...
Domestic drug R&D makes positive strides
China Daily· 7 days ago"From 2015 to last year, China granted market approval for 451 types of innovative drugs, with about a third of them developed by domestic companies," he said. Citing data from online data platform ...
AbbVie's tight grip on Humira market raises concerns about biosimilars By Reuters
Investing.com· 4 days agoHumira, which lists for almost $7,000 a month, is the first top-selling drug to compete with a slew...
